Effect of Chromium Picolinate on Insulin Sensitivity in Type 2 Diabetes

Completed · Phase 4 · Has a placebo group

Conditions studied: Type 2 Diabetes

In brief

The effect of Chromium to improve glucose levels in diabetes is controversial. The hypothesis of the study was to evaluate the effect of supplementing the diet of individuals with Type 2 diabetes with chromium picolinate and assessing the effect of the supplementation on insulin sensitivity as assessed with hyperinsulinemic clamps

Key facts

Study ID

NCT00398853

Run by

Pennington Biomedical Research Center

People needed

100

Starts

2003-10-01

Expected to finish

2009-06-01

Last updated by the study team

2016-04-08

Who can join

Age: 25 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Type 2 diabetes
• On no meds to alter glucose metabolism
• age greater than 25 years old
• Fasting glucose greater than 125 mg/dl at screening

You may not qualify if…

• Subjects on insulin
• Sujbects on meds that alter glucose metabolism
• Use of glitazones
• C0-existing disorders in major organ systems such as heart, kidneys, liver

Where it is running

• Pennington Biomedical Research Center — Baton Rouge, Louisiana, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.